Physician profile
James P Orourke
NPI 1144226598
$8,968.66
in general payments reported to CMS, 2019-2025
25 companies · $546 in 2025
The $546 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $192 · 2021: $1,060 · 2022: $1,915 · 2023: $4,713 · 2024: $114 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $1,494 · Food and Beverage: $1,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $1,493.83 |
| Food and Beverage | $1,379.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,257.08 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Atricure, INC. | $2,642.38 | 2020-2023 | |
| Abiomed | $946.72 | 2019-2025 | Impella |
| Edwards Lifesciences Corporation | $448.09 | 2019-2024 | Mitris Resilia Mitral Valve |
| Medela LLC | $436.02 | 2025 | |
| Medtronic, INC. | $344.65 | 2021-2023 | Corevalve Evolut R |
| Boehringer Ingelheim Pharmaceuticals, INC. | $181.45 | 2019-2023 | Jardiance |
| Abbott Laboratories | $175.26 | 2021-2022 | |
| Amgen INC. | $79.74 | 2021-2023 | Repatha |
| Janssen Pharmaceuticals, INC | $71.05 | 2021-2023 | Xarelto |
| Lsi Solutions INC | $64.06 | 2019-2025 | C1, Cor-Knot |
| Sanofi-Aventis U.S. LLC | $60.76 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.14 | 2021-2023 | Lifevest |
| Amarin Pharma, INC. | $28.73 | 2021 | |
| Medtronic Vascular, INC. | $25.84 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $23.62 | 2023 | Sensation 7fr. 34cc Iab |
| Ethicon US, LLC | $20.42 | 2022 | |
| Corcym INC | $19.48 | 2025 | Perceval |
| Actelion Pharmaceuticals US, INC. | $19.13 | 2020 | |
| Esperion Therapeutics, INC. | $17.83 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $17.34 | 2022 | |
| Merck Sharp & Dohme LLC | $13.94 | 2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $13.64 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.20 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Orourke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.